PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lead titanium trioxide | 235-038-9 | 12060-00-3 | - | - | - | - | - | - | 1 | - | - | Details |
| Lead titanium zirconium oxide | 235-727-4 | 12626-81-2 | - | - | - | - | - | - | 1 | - | - | Details |
|
Lead(II) bis(methanesulfonate)
BLEIMETHANSULFONAT; LEAD (II) METHANESULFONATE; LEAD METHANE SULPHONATE; LEAD SALT FP
|
401-750-5 | 17570-76-2 | - | - | - | - | - | - | 1 | - | - | Details |
| Lecithins, acetylated | 293-316-5 | 91053-50-8 | - | - | 1 | - | - | - | - | - | - | Details |
|
Lemon, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Citrus limonum, Rutaceae.
|
284-515-8 | 84929-31-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Lenacil | 218-499-0 | 2164-08-1 | - | - | - | - | - | 1 | - | - | - | Details |
| Linalool | 201-134-4 | 78-70-6 | - | - | 1 | - | - | - | - | - | - | Details |
|
Linalool; (S,R)-3,7-dimethyl-1,6-octadien-3-ol; dl-linalool Coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool Licareol; (R)-3,7-dimethyl-1,6-octadien-3-ol; l-linalool
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
| Linalyl acetate | 204-116-4 | 115-95-7 | - | - | 2 | - | - | - | - | - | - | Details |
| Linseed oil, epoxidized | 232-401-3 | 8016-11-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Linseed oil, polymerized | 614-114-9 | 67746-08-1 | - | - | 3 | - | - | - | - | - | - | Details |
| Lithium 12-hydroxystearate | 231-536-5 | 7620-77-1 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium bis(fluorosulfonyl)imide | 686-526-7 | 171611-11-3 | - | - | 1 | - | - | - | - | - | - | Details |
|
Lithium bis(oxalato)borate
LITHIUM-BIS(OXALATO)BORATE
|
456-990-3 | 244761-29-3 | - | - | 1 | - | - | - | - | - | - | Details |
|
lithium carbonate; lithium chloride; lithium hydroxide
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
| Lithium docosanoate | 224-801-1 | 4499-91-6 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium isooctadecanoate | 283-815-6 | 84731-55-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium myristate | 243-743-8 | 20336-96-3 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium naphthalene-2-carboxylate | 700-040-5 | 674347-28-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium Nickel Cobalt Aluminium Oxide | 700-042-6 | 177997-13-6 | - | - | 1 | - | - | - | - | - | - | Details |
| lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate | 413-090-5 | - | - | - | 1 | - | - | - | - | - | - | Details |
|
Lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
DIRECT BLUE FC 57087
|
418-870-9 | 154212-58-5 | - | - | - | - | - | 1 | - | - | - | Details |
| Lithium stearate | 224-772-5 | 4485-12-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Lithium tetrafluoroborate, anhydrous | 238-178-9 | 14283-07-9 | - | - | 1 | - | - | - | - | - | - | Details |
|
Long-chain perfluorocarboxylic acids, their salts and related compounds
Long-chain PFCAs and their salts are a homologous series of substances with the molecular formula of CnF2n+1CO2H (where 8 ≤ n ≤ 20). Related compounds are viewed as any substance that is a precursor and may degrade or transform to long-chain PFCAs, where the perfluorinated alkyl moiety has the formula CnF2n+1 (where 8 ≤ n ≤ 20) and is directly bonded to any chemical moiety other than a fluorine, chlorine or bromine atom
|
- | - | - | - | - | - | - | - | - | - | - | Details |